Literature DB >> 22906216

High-resolution computed tomography in assessment of patients with emphysema.

Jeng-Shing Wang1, Jaw-Ming Cherng, Daw-Shyong Perng, Hong-Shen Lee, Sophie Wang.   

Abstract

OBJECTIVE: To assess whether high-resolution computed tomography (HRCT) variables are as good as other known clinical variables in grading emphysema patients.
METHODS: A detailed clinical history was taken and physical examination performed. We performed serum study, lung function testing, and HRCT scanning to assess emphysema. Mean lung density, the attenuation value separating the least 15% of pixels (PERC15), the percentage of the relative area of the lungs with attenuation values < -950 Hounsfield units (HU) (RA950), and histogram analysis were calculated from computerized data.
RESULTS: The final analysis was based on data from 92 subjects, and they were moderately emphysematous (mean lung density was -877 ± 23 HU, PERC15 was -953 ± 21 HU, and RA950 was 16 ± 5%). There was a significant difference regarding subjective emphysema severity in the St George's Respiratory Questionnaire, smoking history, FEV1, C-reactive protein, age, and body mass index (P < .001). There was a significant correlation between the 3 objective image variables and the 6 objective clinical variables (St George's Respiratory Questionnaire, smoking history, FEV1, C-reactive protein, age, and body mass index) (P < .001).
CONCLUSIONS: This study shows the possible important role of HRCT in the diagnosis and quantification of pulmonary emphysema.

Entities:  

Keywords:  emphysema; emphysema severity; high-resolution computed tomography; mean lung density

Mesh:

Substances:

Year:  2013        PMID: 22906216     DOI: 10.4187/respcare.01691

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  3 in total

1.  American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

Authors:  Prescott G Woodruff; Maarten van den Berge; Richard C Boucher; Christopher Brightling; Esteban G Burchard; Stephanie A Christenson; MeiLan K Han; Michael J Holtzman; Monica Kraft; David A Lynch; Fernando D Martinez; Helen K Reddel; Don D Sin; George R Washko; Sally E Wenzel; Antonello Punturieri; Michelle M Freemer; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

2.  Quantification of Perinodular Emphysema in High-risk Patients Offers No Benefit in Lung Nodule Risk-Stratification of Malignancy Potential.

Authors:  William H Amundson; Eric J Swanson; Ashley Petersen; Brian J Bell; Charles Hatt; Chris H Wendt
Journal:  J Thorac Imaging       Date:  2020-03       Impact factor: 3.000

3.  Losartan Effects on Emphysema Progression Randomized Clinical Trial: Rationale, Design, Recruitment, and Retention.

Authors:  Robert A Wise; Janet T Holbrook; Robert H Brown; Gerard J Criner; Mark T Dransfield; MeiLan K Han; Jerry A Krishnan; Ellen Looney; Enid Neptune; Vicky Palombizio; Alexis Rea
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.